Abstract
To investigate the efficacy of HA380 hemoadsorption during cardiopulmonary bypass (CPB) in reducing postoperative delirium (POD) and improving clinical outcomes in elderly cardiac surgery patients. A prospective, single-center, evaluator-blinded, randomized controlled trial. Single institution, tertiary university hospital. 130 patients were randomized (HA380 n = 65; control n = 65), with 128 included in the complete-case primary analysis (64 per group). Eligible patients were aged ≥ 65 years and scheduled for cardiac surgery under CPB with anticipated duration > 2 h. The intervention group received HA380 hemoadsorption integrated into the CPB circuit; the control group underwent standard CPB. Outcome assessors remained blinded to group allocation. The primary endpoint was POD incidence within 7 days postoperatively, assessed using the confusion assessment method. Secondary outcomes included inflammatory biomarkers (TNF-α, IL-6, IL-10), liver function markers (ALT, AST, CRP), renal function (creatinine, procalcitonin), and postoperative complications. The primary unadjusted analysis showed a significantly lower incidence of delirium in the HA380 group versus controls (28.1% [18/64] vs 51.6% [33/64]; unadjusted OR 0.38, 95% CI 0.18–0.81; P = 0.012). Multivariable adjustment (primary analysis per locked SAP v1.0 Model I: age and hypertension) yielded an adjusted OR of 0.42 (95% CI 0.19–0.91; P = 0.028), with consistent results in sensitivity analysis additionally adjusting for coronary artery disease (OR 0.41, 95% CI 0.18–0.89; P = 0.025). Results were robust in random-forest multiple-imputation sensitivity analyses. HA380 significantly attenuated inflammatory markers (permutation P < 0.01 for IL-6, IL-10, and TNF-α at surgery-end/24 h) and significantly reduced ALT levels (permutation P = 0.015). However, no significant differences were observed for AST, CRP, creatinine, procalcitonin, mechanical ventilation duration, ICU length of stay, total hospital stay, or postoperative complications. Exploratory analyses suggested shorter delirium duration among patients who developed POD in the HA380 group (median 3 [2–3] vs 4 [3–5] days, P = 0.021). In this single-center, preliminary efficacy trial, HA380 hemoadsorption during CPB significantly reduced POD incidence in elderly cardiac surgery patients. These findings require confirmation in larger, multicenter, adequately powered trials with pre-specified secondary hierarchies and long-term cognitive follow-up.
Similar content being viewed by others
Data availability
The datasets generated and analyzed during the current study are owned by Fujian Provincial Hospital and are not publicly available. De-identified data may be made available from the corresponding author upon reasonable request and with permission from the hospital.
References
Brown, C. H. Delirium in the cardiac surgical ICU. Curr. Opin. Anaesthesiol. 27, 117–122. https://doi.org/10.1097/aco.0000000000000061 (2014).
Brown, CHt. et al. Cognitive decline after delirium in patients undergoing cardiac surgery. Anesthesiology 129, 406–416. https://doi.org/10.1097/aln.0000000000002253 (2018).
Hála, M. Pathophysiology of postoperative delirium: Systemic inflammation as a response to surgical trauma causes diffuse microcirculatory impairment. Med. Hypotheses 68, 194–196. https://doi.org/10.1016/j.mehy.2006.07.003 (2007).
Giacinto, O. et al. Inflammatory response and endothelial dysfunction following cardiopulmonary bypass: Pathophysiology and pharmacological targets. Recent Pat. Inflamm. Allergy Drug Discov. 13, 158–173. https://doi.org/10.2174/1872213x13666190724112644 (2019).
Reinsfelt, B. et al. Cerebrospinal fluid markers of brain injury, inflammation, and blood-brain barrier dysfunction in cardiac surgery. Ann. Thorac. Surg. 94, 549–555 (2012).
Wilson, J. E. et al. Delirium. Nat. Rev. Dis. Primers 6, 90. https://doi.org/10.1038/s41572-020-00223-4 (2020).
Hellman, T., Uusalo, P. & Järvisalo, M. J. Renal replacement techniques in septic shock. Int. J. Mol. Sci. https://doi.org/10.3390/ijms221910238 (2021).
Pomarè Montin, D. et al. Biocompatibility and cytotoxic evaluation of new sorbent cartridges for blood hemoperfusion. Blood Purif. 46, 187–195. https://doi.org/10.1159/000489921 (2018).
He, Z. et al. The efficacy of resin hemoperfusion cartridge on inflammatory responses during adult cardiopulmonary bypass. Blood Purif. 51, 31–37. https://doi.org/10.1159/000514149 (2022).
Wang, J. et al. Effects of blood hemoadsorption therapy with HA-380 in total arch replacement for acute type A aortic dissection: A retrospective observational study. Blood Purif. 53, 138–150. https://doi.org/10.1159/000534852 (2024).
Konietschke, F., Placzek, M., Schaarschmidt, F. & Hothorn, L. A. nparcomp: An R software package for nonparametric multiple comparisons and simultaneous confidence intervals. J. Stat. Softw. 64, 1–17 (2015).
Gueorguieva, R. & Krystal, J. H. Move over ANOVA: Progress in analyzing repeated-measures data and its reflection in papers published in the archives of general psychiatry. Arch. Gen. Psychiatry. 61, 310–317. https://doi.org/10.1001/archpsyc.61.3.310 (2004).
North, B. V., Curtis, D. & Sham, P. C. A note on calculation of empirical P values from Monte Carlo procedure. Am. J. Hum. Genet. 72, 498–499. https://doi.org/10.1086/346173 (2003).
Davison, A. C. & Hinkley, D. V. Bootstrap methods and their application (Cambridge University Press, 1997).
Rubin, D. (J Wiley and Sons, 1987).
Stekhoven, D. J. & Bühlmann, P. MissForest--Non-parametric missing value imputation for mixed-type data. Bioinformatics 28, 112–118. https://doi.org/10.1093/bioinformatics/btr597 (2012).
Zhang, Y., Ding, X., Miao, C. & Chen, J. Propofol attenuated TNF-α-modulated occludin expression by inhibiting Hif-1α/ VEGF/ VEGFR-2/ ERK signaling pathway in hCMEC/D3 cells. BMC Anesthesiol. 19, 127. https://doi.org/10.1186/s12871-019-0788-5 (2019).
Pérez-Fernández, X. et al. Extracorporeal blood purification and acute kidney injury in cardiac surgery: The SIRAKI02 randomized clinical trial. JAMA 332, 1446–1454. https://doi.org/10.1001/jama.2024.20630 (2024).
Acknowledgements
The authors thank Dr. Lin Qun for initial conceptual discussions.
Funding
This work was supported by the China Association for Promotion of Health Science and Technology Research Fund.
Author information
Authors and Affiliations
Contributions
Min Chen: Writing—review & editing, Formal analysis, Data curation, Investigation Yanlin Wu: Writing—review & editing, Formal analysis, Data curation, Investigation Siling Zou: Methodology, Writing—review & editing, Writing—original draft Meiyan Chen: Writing—review & editing, Investigation Qiaoping Liu: Writing—review & editing, Investigation Lihua Lei: Methodology, Investigation, Formal analysis, Conceptualization, Writing—review & editing.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Ethical approval
The study was approved by the Ethics Committee of [Affiliated Provincial Hospital of Fuzhou University] (Approval No. [K2022-10-012]) and registered with the China Clinical Trial Registry (ChiCTR2400085575). Written informed consent was obtained from all participants before enrollment.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.
About this article
Cite this article
Chen, M., Wu, Y., Zou, S. et al. Effect of HA380 hemoadsorption on postoperative delirium in elderly cardiac surgery patients: a randomized controlled trial. Sci Rep (2026). https://doi.org/10.1038/s41598-026-46907-x
Received:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41598-026-46907-x
